Lipids, Gut Microbiota, and the Complex Relationship with Alzheimer’s Disease: A Narrative Review
Nutrients · 03.11.2023 · 15 (21) · 4661
DOI: 10.3390/nu15214661 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 03.11.2023. Verfasst von Daiane Oliveira Simão und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Federal University of Minas Gerais, Professor Alfredo Balena Avenue, 190, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s Disease (AD) is a multifactorial, progressive, and chronic neurodegenerative disorder associated with the aging process. Memory deficits, cognitive impairment, and motor dysfunction are characteristics of AD. It is estimated that, by 2050, 131.5 million people will have AD. There is evidence that the gastrointestinal microbiome and diet may contribute to the development of AD or act preventively. Communication between the brain and the intestine occurs through immune cells in the mucosa and endocrine cells, or via the vagus nerve. Aging promotes intestinal dysbiosis, characterized by an increase in pro-inflammatory pathogenic bacteria and a reduction in anti-inflammatory response-mediating bacteria, thus contributing to neuroinflammation and neuronal damage, ultimately leading to cognitive decline. Therefore, the microbiota–gut–brain axis has a significant impact on neurodegenerative disorders. Lipids may play a preventive or contributory role in the development of AD. High consumption of saturated and trans fats can increase cortisol release and lead to other chronic diseases associated with AD. Conversely, low levels of omega-3 polyunsaturated fatty acids may be linked to neurodegenerative diseases. Unlike other studies, this review aims to describe, in an integrative way, the interaction between the gastrointestinal microbiome, lipids, and AD, providing valuable insights into how the relationship between these factors affects disease progression, contributing to prevention and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Federal University of Minas Gerais, Professor Alfredo Balena Avenue, 190, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil.
- Department of Nutrition, School of Nursing, Federal University of Minas Gerais, Professor Alfredo Balena Avenue, 190, Santa Efigênia, Belo Horizonte 30130-100, MG, Brazil.
- Department of Clinical and Toxicological Analyzes, Faculty of Pharmacy, Federal University of Minas Gerais, Presidente Antônio Carlos Avenue, 6627, Pampulha, Belo Horizonte 31270-901, MG, Brazil.
ORCID-Profile: Vitoria Silva Vieira, Karina Braga Gomes
Zitieren
APA
Simão, D. O., Vieira, V. S., Tosatti, J. A. G., & Gomes, K. B. (2023). Lipids, Gut Microbiota, and the Complex Relationship with Alzheimer’s Disease: A Narrative Review. Nutrients, 15(21), 4661. https://doi.org/10.3390/nu15214661
Vancouver
Simão DO, Vieira VS, Tosatti JAG, Gomes KB. Lipids, Gut Microbiota, and the Complex Relationship with Alzheimer’s Disease: A Narrative Review. Nutrients. 2023;15(21):4661. doi:10.3390/nu15214661
BibTeX
@article{Simo2023,
author = {Simão, Daiane Oliveira and Vieira, Vitoria Silva and Tosatti, Jéssica Abdo Gonçalves and Gomes, Karina Braga},
title = {Lipids, Gut Microbiota, and the Complex Relationship with Alzheimer’s Disease: A Narrative Review},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {21},
pages = {4661},
doi = {10.3390/nu15214661}
}
EUVIMED